Revenue and adjusted EBITDA declined year-over-year due to U.S. segment weakness and major impairment charges, while Canadian operations delivered modest growth and improved margins. Free cash flow rose sharply, and the quarterly dividend was increased by 7%.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.